Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
1.01
-0.02 (-1.94%)
At close: May 30, 2025, 3:57 PM
1.02
0.99%
After-hours: May 30, 2025, 04:04 PM EDT
Lexaria Bioscience Revenue Breakdown
| Period Ending | Aug 31, 2021 |
|---|---|
| B2B Revenue | 297.28K |
| B2B Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.24M | 918.69K | 1.32M | 1.25M | 551.29K | 711.11K | 566.67K | 823.32K | 644.51K | 1.03M | 1.23M | 1.75M | 1.2M | 1.55M | 1.08M | 2.16M | 994.54K | 734.75K | 796.02K | 1.34M | 832.83K | 802.44K | 945.5K | 994.78K | 1.09M | 613.24K | 1.11M | 3.47M | 1.46M | 477.25K | 651.13K | 347.42K | 446.9K | 396.4K | 316.63K | 248.74K | 239.57K | 392.11K | 500.03K | 497.86K | 450.12K |
| Selling, General, and Administrative Revenue Growth | +34.88% | -30.39% | +5.27% | +127.43% | -22.47% | +25.49% | -31.17% | +27.74% | -37.15% | -16.41% | -29.79% | +45.94% | -22.91% | +43.32% | -49.79% | +117.02% | +35.36% | -7.70% | -40.70% | +61.18% | +3.79% | -15.13% | -4.95% | -8.71% | +77.70% | -44.54% | -68.10% | +137.54% | +205.70% | -26.70% | +87.42% | -22.26% | +12.74% | +25.19% | +27.30% | +3.83% | -38.90% | -21.58% | +0.44% | +10.61% | n/a |
| Research and Development Revenue | 1.69M | 1.95M | 967.21K | 573.09K | 245.78K | 574.49K | 500.41K | 1.64M | 696.18K | 829.49K | 356.19K | 752.1K | 275.69K | 458.71K | 439.79K | 454.44K | 176.4K | 192.26K | 68.5K | 24.56K | 186.56K | 107.46K | 161.64K | 231.03K | 66.08K | 96.97K | 213.64K | 93.07K | 75.76K | 110.39K | 30.91K | 8.24K | 7.78K | 7.26K | 37 | 158 | 6.85K | 1.98K | 98.08K | 107 | 240 |
| Research and Development Revenue Growth | -13.69% | +101.94% | +68.77% | +133.17% | -57.22% | +14.80% | -69.50% | +135.67% | -16.07% | +132.88% | -52.64% | +172.81% | -39.90% | +4.30% | -3.22% | +157.62% | -8.25% | +180.69% | +178.93% | -86.84% | +73.60% | -33.52% | -30.04% | +249.61% | -31.85% | -54.61% | +129.56% | +22.84% | -31.37% | +257.19% | +275.07% | +5.94% | +7.12% | +19524.32% | -76.58% | -97.69% | +246.36% | -97.98% | +91563.55% | -55.42% | n/a |